Medicare Enrolled
Dr. Daniel Glatt, MD
Internal Medicine · Burlingame, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Glatt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glatt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glatt
Dr. Daniel Glatt is an internal medicine specialist in Burlingame, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Glatt performed 2,638 Medicare services across 1,331 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glatt received a total of $73,615 from 75 pharmaceutical and/or device companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glatt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in CA
$73,615 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,638
Medicare services
Top 12% in CA for internal medicine
1,331
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
919 | $109 | $325 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
661 | $12 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $79 | $275 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
151 | $92 | $160 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
128 | $157 | $275 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
125 | $37 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
105 | $76 | $127 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
56 | $159 | $450 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
35 | $37 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $146 | $460 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
21 | $282 | $350 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
20 | $52 | $120 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
19 | $33 | $62 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
14 | $131 | $181 |
| New patient office visit, complex (60-74 min) | 11 | $192 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$73,615
Total received (2018-2024)
Avg $10,516/year across 7 years
Top 2% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
971
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53,228 (72.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,799 (18.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,588 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,840
2023
$4,554
2022
$4,998
2021
$7,955
2020
$10,239
2019
$12,328
2018
$31,702
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$295
Novo Nordisk Inc
$224
PFIZER INC.
$183
AstraZeneca Pharmaceuticals LP
$130
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$116
Collegium Pharmaceutical, Inc.
$101
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
IDORSIA PHARMACEUTICALS US INC
$85
GlaxoSmithKline, LLC.
$77
Axsome Therapeutics, Inc.
$63
Braeburn Inc.
$59
Lilly USA, LLC
$58
Verity Pharmaceuticals Inc.
$52
Otsuka America Pharmaceutical, Inc.
$48
Edwards Lifesciences Corporation
$42
Phathom Pharmaceuticals, Inc.
$26
Almatica Pharma LLC
$24
Vanda Pharmaceuticals Inc.
$24
Esperion Therapeutics, Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Seqirus USA Inc
$20
Indivior Inc.
$20
Alkermes, Inc.
$19
Masimo Corporation
$17
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
Indivior Inc.
$30,940
Alkermes, Inc.
$23,008
BioDelivery Sciences International, Inc.
$5,994
ABBVIE INC.
$1,066
Novo Nordisk Inc
$973
Collegium Pharmaceutical, Inc.
$944
PFIZER INC.
$909
Boehringer Ingelheim Pharmaceuticals, Inc.
$881
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$710
AstraZeneca Pharmaceuticals LP
$633
Takeda Pharmaceuticals U.S.A., Inc.
$479
Lilly USA, LLC
$475
Sunovion Pharmaceuticals Inc.
$429
AbbVie Inc.
$396
GlaxoSmithKline, LLC.
$369
Astellas Pharma US Inc
$368
Otsuka America Pharmaceutical, Inc.
$294
Janssen Pharmaceuticals, Inc
$260
Merck Sharp & Dohme Corporation
$227
Amgen Inc.
$225
RedHill Biopharma Inc.
$216
Teva Pharmaceuticals USA, Inc.
$210
Bausch Health US, LLC
$207
AbbVie, Inc.
$207
Allergan, Inc.
$186
IDORSIA PHARMACEUTICALS US INC
$164
Lundbeck LLC
$163
Merck Sharp & Dohme LLC
$156
Orexo US, Inc.
$150
Axsome Therapeutics, Inc.
$146
Gilead Sciences, Inc.
$144
Allergan Inc.
$143
Novartis Pharmaceuticals Corporation
$139
Seqirus USA Inc
$134
Eisai Inc.
$120
ITI, Inc.
$117
Biohaven Pharmaceutical Holding Company Ltd.
$96
Biohaven Pharmaceuticals, Inc.
$93
Braeburn Inc.
$84
E.R. Squibb & Sons, L.L.C.
$65
Medicure Pharma Inc.
$63
Daiichi Sankyo Inc.
$55
Vanda Pharmaceuticals Inc.
$53
Verity Pharmaceuticals Inc.
$52
Covis Pharma GmBH
$50
Boston Scientific Corporation
$47
Esperion Therapeutics, Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$45
ASSERTIO THERAPEUTICS, Inc.
$44
Edwards Lifesciences Corporation
$42
Kowa Pharmaceuticals America, Inc.
$38
SANOFI-AVENTIS U.S. LLC
$37
Forte Bio-Pharma LLC
$37
Shionogi Inc
$36
Hikma Pharmaceuticals USA
$35
US WorldMeds, LLC
$35
Avanir Pharmaceuticals, Inc.
$31
INSYS Therapeutics Inc
$28
Phathom Pharmaceuticals, Inc.
$26
Almatica Pharma LLC
$24
Alfasigma USA, Inc.
$23
Dova Pharmaceuticals
$23
JAZZ PHARMACEUTICALS INC.
$22
Abbott Laboratories
$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Kaleo, Inc.
$21
Synergy Pharmaceuticals Inc
$19
IRONWOOD PHARMACEUTICALS, INC
$18
Masimo Corporation
$17
Pernix Therapeutics Holdings, Inc.
$16
Antares Pharma, Inc.
$16
Circassia Pharmaceuticals Inc
$15
Horizon Therapeutics plc
$15
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$13
Nevro Corp.
$12
Top 3 companies account for 81.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIMOVIG · AIRSUPRA · AJOVY · AMITIZA · ANORO · APLENZIN · AREXVY · AUSTEDO · Aemcolo · Aimovig · Amitiza · Androgel · Auvelity · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BOOSTRIX · BREZTRI · BRINTELLIX · BRIXADI · BUNAVAIL 2.1 mg 30-count box · BYDUREON · BYSTOLIC · Belbuca · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cambia · Creon · DUAKLIR PRESSAIR · Dayvigo · Dexilant · Doptelet · ELIQUIS · EMGALITY · EVZIO · FANAPT · FARXIGA · FLUCELVAX QUADRIVALENT · Fluad Quadrivalent · Flucelvax · Gralise · HETLIOZ · HMG-CoA reductase inhibitor. · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Kloxxado · LATUDA · LINZESS · LOREEV XR · LUCEMYRA · LYRICA · Linzess · Livalo · Lucemyra/Lofexidine · MIGRANAL · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Morphabond ER · Motegrity · Movantik · Myrbetriq · NEXLETOL · NURTEC ODT · Nuedexta · OTREXUP · Omnia · Ozempic · PENNSAID · PREVNAR 13 · PREVNAR 20 · PROCLAIM · PROLATE · Patient SafetyNet System · Prandin · QTERN · QULIPTA · QUVIVIQ · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · Rybelsus · SAPIEN 3 Ultra RESILIA · SHINGRIX · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUBSYS · SUNOSI · SYMBICORT · SYNJARDY · Saxenda · Sunosi · Symproic · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Talicia · Tlando · Trintellix · Trulance · UBRELVY · VESICARE · VIBERZI · VIIBRYD · VIVITROL · VOQUEZNA · VRAYLAR · Victoza · Vivitrol · Vivitrol 380 mg · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
3,537
Per 100K population
474.7
County median income
$156,000
Nearest hospital
PENINSULA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glatt is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glatt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Glatt performed 919 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glatt receive payments from pharmaceutical companies?
Yes. Dr. Glatt received a total of $73,615 from 75 companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glatt's costs compare to other internal medicine physicians in Burlingame?
Dr. Glatt's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glatt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Burlingame
Browse internal medicine physicians in Burlingame ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Indivior Inc. Payments to Doctors
See all physicians who received payments from Indivior Inc.
By company
Alkermes, Inc. Payments to Doctors
See all physicians who received payments from Alkermes, Inc.
By company
BioDelivery Sciences International, Inc. Payments to Doctors
See all physicians who received payments from BioDelivery Sciences International, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology